Trafford Clarke serves as Executive at Traws Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Trafford Clarke has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved receiving (via award) 6,157 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | TRAW | $0 | Award | 6,157 | $N/A | Discretionary |
Trafford Clarke currently holds 6,157 shares of Traws Pharma, Inc. (TRAW), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Trafford Clarke has been a net neutral trader of TRAW stock. They have purchased $0 and sold $0 worth of shares.
Trafford Clarke's most recent insider trade was on Dec 12, 2025, when they sold 6,157 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted